1. Nellie Turner presented with symptoms of lactational mastitis including breast engorgement, erythema, firmness, and fever. She was initially treated with cephalexin antibiotics but symptoms persisted.
2. After consultation, she was prescribed trimethoprim/sulfamethoxazole which resolved her symptoms within 10 days of treatment. Continued breastfeeding and supportive measures were encouraged to aid recovery.
3. Lactational mastitis requires prompt treatment, usually with antibiotics, to prevent complications while encouraging continued breastfeeding for optimal infant and maternal health outcomes.
Invited Lecture delivered by Dr Sujoy Dasgupta in a CME, sponsored by Serum Institute of India Pvt Ltd in the Convocation Ceremony of Interns at Sagor Dutta Medical College
UNEXPLAINED INFERTILITY &INTRAUTERINE INSEMINATION Dr. Sharda jain Lifecare...Lifecare Centre
UNEXPLAINED INFERTILITY &INTRAUTERINE INSEMINATION DR. SHARDA JAIN , DR. JYOTI AGARWAL
DR. JYOTI BHASKAR
DEFINITION
Unexplained infertility means that couple does not conceive after 1year of unprotected vaginal sexual intercourse, with basic infertility evaluation showing no obvious abnormality.
INCIDENCE
15%to 20% of infertile couples
UNEXPLAINED IS PRIMARILY A
DIAGNOSIS OF EXCLUSION
Invited Lecture delivered by Dr Sujoy Dasgupta in a CME, sponsored by Serum Institute of India Pvt Ltd in the Convocation Ceremony of Interns at Sagor Dutta Medical College
UNEXPLAINED INFERTILITY &INTRAUTERINE INSEMINATION Dr. Sharda jain Lifecare...Lifecare Centre
UNEXPLAINED INFERTILITY &INTRAUTERINE INSEMINATION DR. SHARDA JAIN , DR. JYOTI AGARWAL
DR. JYOTI BHASKAR
DEFINITION
Unexplained infertility means that couple does not conceive after 1year of unprotected vaginal sexual intercourse, with basic infertility evaluation showing no obvious abnormality.
INCIDENCE
15%to 20% of infertile couples
UNEXPLAINED IS PRIMARILY A
DIAGNOSIS OF EXCLUSION
Prelabour Rupture of Membrane (PROM) by Sunil Kumar Dahasunil kumar daha
Please find the power point on Prelabour Rupture of Membrane (PROM). I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Selective progesterone receptor modulators (SPRMs)
Stimulates growth :
Up regulating epidermal growth factor (EGF)
Down regulating tumour necrosis factor-alpha expression
Inhibits growth :
Downregulating insulin-like growth factor-1 (IGF-1) expression
NO EFFECT ON ESTRADIOL LEVELS
Mifepristone : 5 or 10 mg per day for 1 year
Ulipristal acetate: 5-10mg/day for 13 weeks
Pro apoptotic and anti-proliferative effects on fibroid cells
Prelabour Rupture of Membrane (PROM) by Sunil Kumar Dahasunil kumar daha
Please find the power point on Prelabour Rupture of Membrane (PROM). I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Selective progesterone receptor modulators (SPRMs)
Stimulates growth :
Up regulating epidermal growth factor (EGF)
Down regulating tumour necrosis factor-alpha expression
Inhibits growth :
Downregulating insulin-like growth factor-1 (IGF-1) expression
NO EFFECT ON ESTRADIOL LEVELS
Mifepristone : 5 or 10 mg per day for 1 year
Ulipristal acetate: 5-10mg/day for 13 weeks
Pro apoptotic and anti-proliferative effects on fibroid cells
Postnatal care (PNC) for the mother should respond to her special needs, starting within an hour after the delivery of the placenta and extending through the following six weeks. The care includes the prevention, early detection and treatment of complications, and the provision of counselling on breastfeeding, birth spacing, immunization and maternal nutrition. To standardise the PNC service, you are advised to use the screening, counselling and postnatal care cards. These cards ensure that you have covered all the essential steps in every home visit.
this ppt is beneficial for nursing and obstetric and gynaecology students.
BFHI, Exclusive breastfeeing, Breastfeeding technique, pattern of feedingpoonambiswas4
breastfeeding should be given exclusively in our country as our country has so many incidence of malnutrition. BFHI is doing their work to promote successful breastfeeding.
after 6 months complementary feeding should be there
family food should be introduced after 6 months of age
no prelacteal food should be given
Primary Maternal Care: The puerperium and family planningSaide OER Africa
Primary Maternal Care addresses the needs of healthcare workers in level 1 district hospitals and clinics who provide antenatal and postnatal care, but do not conduct deliveries. It is adapted from theory chapters and skills workshops from Maternal Care. This book complements the national protocol of antenatal care in South Africa. It covers: booking for antenatal care, assesing fetal growth and wellbeing, hypertensive disorders of pregnancy, antepartum haemorrhage, preterm labour, important medical conditions
Dr. Gaurav Gupta - Should you be buying an E-bike this Diwali?
Dr RP Bansal- Feeding difficulties in the newborn
Dr Nivedita- Tips on how to Continue Breast Feeding
Dr Ridhi- Teething tips
Dr Arushi - First afebrile seizure
Dr Amit - Mesentric lymphadenopathy
Dr Gunjan - Acute events following immunization plus update on BCG adenitis
Dr Sandip Jain- Tips for examining children
Dr Diljot - Mefenemic acid as an antipyretic
Dr Jaskaran- colicky infant : knowledge , attitude and practices
Dr Shailesh - School se chutti kitne din karayein ?
Dr Gaurav- Is it oral Herpes? Visual Quiz
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
How to Give Better Lectures: Some Tips for Doctors
Rzepka, v therapeutics 1 mastitis presentation
1. KEEPING
ABREAST
Therapeutic choices for the
treatment of lactational mastitis.
Valerie Rzepka, NP-PHC Student
2. Nellie Turner
History of Presenting Illness: 31 years old
• Mid-October, presented at ER (pseudonym)
with:
• right breast engorgement
• erythema
• Firmness
• edema
• generalized malaise
• fever
• chills
• Treated for lactational mastitis
with Cephalexin 500mg po, qid x
10 days
• Returned after completion of
antibiotics for continued
unresolved symptoms.
• Cephalexin extended for 5 days.
• Returned 1 week later with
continued, unresolved
symptoms
3. Nellie Turner
Past Medical History 31 years old
(pseudonym)
• Nellie reports her health to be
quite good:
• Planned pregnancy, previously used
NuvaRing for contraception.
• Mild anemia during pregnancy
• Mild eczema in the winter months,
• Occasional migraines
• Chronic neck and back pain
secondary to MVC in 1996
• Deviated nasal septum – ENT Surgery
deferred due to pregnancy.
• No chronic medical conditions,
• No known allergies,
• She denies weight loss and change in
diet.
• Reports significant change in her
energy, activity level and sleep
pattern since the onset of the
infection.
4. Nellie Turner
Past Medical History
31 years old
(pseudonym)
• Gravida 1, Para 1. Followed by
Nottawasaga Midwives for this
unremarkable first pregnancy.
• Spontaneous Vaginal Delivery of
a healthy baby boy at 38 weeks
gestation on July 10, 2012.
• Baby is solely breastfed every
three to four hours or on
demand.
• Aside from cracked nipples,
treated with a lanolin-based
over-the-counter ointment, has
had no issues with lactation,
latch or suck.
5. Nellie Turner
31 years old
Baby Jonah (pseudonym) (pseudonym)
• Baby born via SVD, weight: 3620g.
(7.9lbs)
• Satisfactorily growing and gaining
weight according to the growth
chart.
• Currently 4 months
old, active, alert, and is meeting
all of his developmental
milestones.
• Feeds every 3 to 4 hours, and has
6 to 7 heavy wet diapers per
day, along with 2 to 3 yellow
seedy stools.
• Since initiation of antibiotics in
October, Nellie reports Jonah
has been having loose green
stools, but no other ill effects.
7. • Inflammatory condition of the breast3,5
• May or may not be accompanied by infection.1,3.
• Usually associated with lactation, so it is also called
“lactational mastitis”1
• Occurs in 9-12% of all breastfeeding women2,3,4,5
• Most common in the 2nd or 3rd week of
breastfeeding, but can occur at any time. 2,5
• Usually associated with Staphylococcus aureus (S.
aureus), introduced through a break in the skin
(cracked nipple), which characteristically can also
cause abscess development.4
• Nellie reports having cracked nipples in the week
prior to the infection.
8. • Risk Factors associated with Mastitis:5
• Cleft lip or palate
• Cracked nipples
• Infant attachment difficulties
• Local milk stasis
• Missed feedings
• Nipple piercing
• Plastic-backed breast pads
• Poor maternal nutrition
• Previous mastitis
• Primiparity
• Restriction from a tight bra
• Short frenulum in infant
• Sore nipples
• Use of a manual breast pump
• Yeast infection
10. 1. To provide prompt and effective
treatment so to prevent complications
such as an abscess.
2. To provide effective pain relief.
3. To encourage continued
breastfeeding.
11. Non-Pharmacological
• Improved breastfeeding technique/ alternative positions. 5
• Continuation of breastfeeding, especially on affected breast, as often as
possible.
• Milk from a breast with mastitis contains increased levels of some anti-inflammatory
components that may be protective for the infant.
• Some infants may dislike the taste of milk from the infected breast, possibly because of
the increased sodium content.5
• Holding the infant with the chin towards the affected part of the breast, helps to
facilitate milk removal from that section
• Apply heat: warm compresses, warm bath or shower;
• Gentle massage of any lumpy areas while the infant is feeding to help the
milk to flow
• Avoid anything that could obstruct the flow of milk, such as tight clothes or
bra
• Mom should drink plenty of fluids and get lots of rest 5
• Application of Cabbage Leaves 17 or Sliced Potatoes 16 to the breast have no
scientifically proven efficacy, but anecdotal reports are supportive.
12. Non-Pharmacological –
Lactation Consultation and Counselling
• Mastitis is painful and frustrating, makes many women
feel very ill, and can leave infants unsatisfied after
feeding.
• In addition to effective treatment and control of pain,
a woman needs emotional support.
• May have received conflicting advice from
professionals, family members or friends. May have
been advised to stop breastfeeding, or given no
guidance either way. May be confused and anxious,
and unwilling to continue breastfeeding.
• Needs reassurance about value of breastfeeding; it is
safe to continue; milk from the affected breast will not
harm infant, and that breast will recover both its
shape and function subsequently.
• Needs encouragement
• Needs clear guidance about all measures needed for
treatment, and how to continue breastfeeding or
expressing milk from the affected breast.
• Will need follow up to give continuing support and
guidance until she has recovered fully.
14. Mastitis Adapted from: Mastitis Lactational Algorithm
http://www.thewomens.org.au/MastitisLactationalAlgorithm
Heat, rest and drain the 24 hrs
breast
• Keep feeding frequently
• Heat before feeds
• Massage during feeds
• Analgesia (Tylenol or Advil)
No Pharmacological
Generalized Alternatives
symptoms present?
• Fever
• Aches
• Lethargy
Yes
15. Pharmacological Commence
Alternatives Antibiotics
If no overall
improvement
Redness/
in 48 hours,
hard after 5
return to
If improving: days:
clinic.
Complete Continue
course of antibiotics
antibiotics. x 10 days
Milk for
Ultra C&S
sound
to r/o
abscess
Refer/ Admission
Adapted from: Mastitis Lactational Algorithm for IV Abx
http://www.thewomens.org.au/MastitisLactationalAlgorithm
16. Pharmacological
• Antibiotic treatment is indicated if either:
• cell and bacterial colony counts and culture are available and indicate
infection, or
• a nipple fissure is visible, or
• symptoms do not improve after 12-24 hours of improved milk removal, or
• symptoms are severe from the beginning.
17. Pharmacological : 5, 7,9, 10, 11, 12, 13, 14, 15
• Amoxicillin/clavulanate, (AmoxiClav) 875 mg twice daily
• Cephalexin, (Keflex), 500 mg four times daily
• Ciprofloxacin, (Cipro), 500 mg twice daily
• Clindamycin, (Biaxin), 300 mg four times daily
• Cloxacillin, 500 mg four times daily
• Trimethoprim/sulfamethoxazole (Bactrim, Septra), 160 mg/800 mg twice
daily
Usual courses of oral antibiotics are 10 to 14 days.
If patient wishes to continue breastfeeding, safety of the infant
must be considered.
18. Nellie Turner
31 years old
(pseudonym)
Prescription Drug Name etc. Dose, Route, Freq, Duration Rating (1-5) NP Pick
C A S E S
Amoxicillin/clavulanate, 875 mg, bid x 10 days 4 1 4 1 ✓
(Clavulin)
Cephalexin, 500 mg, qid x 10 days 4 5 3 1 5 ✓ ✓
(Keflex)
Ciprofloxacin, 500 mg bid x 10 days 4 1 5 1 ✓
(Cipro)
Cloxacillin 500 mg qid x 10 days 4 5 3 2 5 ✓
Trimethoprim/ sulfamethoxazole 160 mg/800 mg bid x 10 1 1 1 3 1 ✓ ✓
(Bactrim, Septra) days
Ref: 5, 7,9, 10, 11, 12, 13, 14, 15
19. Nellie Turner
31 years old
Consultation – Collaborating physician 10: (pseudonym)
• Nellie returned after her 10-day course of Cephalexin 500mg qid with
unresolved symptoms
• Cephalexin was extended for 5 days, and Nellie was ordered a breast
ultrasound
• She returned again once antibiotics were complete, with continued
unresolved symptoms. Ultrasound was clear.
• Collaborating physician was consulted, and recommended a course of
Trimethoprim/ Sulfamethoxazole 160/800mg bid x 10 days.
20. Referral10 - General Surgery:
• if ultrasound shows breast abscess;
• for needle aspirate, or incision and drainage of abscess.
21. Nellie Turner
31 years old
(pseudonym)
The Therapeutic I Community Health Centre
123 University Avenue, Anytown, ON. N0N 0N0
Phone 416-321-0987
_________________________________________________
Name: Nellie Turner (DOB: January 1, 1981, NKDA)
Address: 1000 Fantasy Lane, Anytown, ON. L0R1B0
Date: November 22, 2012
Trimethoprim/ sulfamethoxazole 160 mg/800 mg
bid x 10 days.
Take one tablet by mouth, twice daily until finished.
M: 20 tabs
R: 0 repeats
Nancy Nurse RN (EC), 54321 (signed)
Nancy Nurse, RN (EC), 54321 (printed)
22. Nellie Turner
Monitoring and Follow up
31 years old
(pseudonym)
• Important to monitor baby Jonah to signs of
dehydration, or secondary infection (e.g. thrush)
• Client returned after the 10-day course of, reporting
that symptoms have nearly entirely resolved, her
energy level had returned, and the erythema and had
engorgement had disappeared.
• The painful, firm thickening has nearly completely
resolved.
Acceptability
• Client was satisfied with resolution, happy to return to
normal functioning, and glad that Baby Jonah continued
to do well.
23.
24. 1. WorldHealthOrganization. (2000). Mastitis: Causes and management. Geneva:WHO.
Retrieved from:
http://www.who.int/maternal_child_adolescent/documents/fch_cah_00_13/en/
2. Foxman, B., D'Arcy, H., Gillespie, B., Bobo, J. K., & Schwartz, K. (2002). Lactation
Mastitis: Occurrence and Medical Management among 946 Breastfeeding Women
in the United States. American Journal of Epidemiology 155(2) pp. 103-114.
3. Jahanfar S, Ng CJ, Teng CL. (2009). Antibiotics for mastitis in breastfeeding women.
Cochrane Database of Systematic Reviews 1.
4. Amir, L.H., Forster, D., McLachlan, H., & Lumley J. (2004). Incidence of breast
abscess in lactating women: report from an Australian cohort. BJOG: an
International Journal of Obstetrics and Gynaecology 111. pp. 1378–1381
5. Spencer, J. (2008). Management of mastitis in breastfeeding women. American
family physician. 78 (6). PP.727-732.
6. The Royal Womens’ Hospital. (2012). Mastitis: lactational (algorithm). Parkville, VIC.
Australia. Retrieved from:
http://www.thewomens.org.au/MastitisLactationalAlgorithm.
7. Lawrence R.A., & Lawrence, R.M. (2011). Breastfeeding: A Guide for the Medical
Professions. 7th ed,. Maryland Heights, MO: Elsevier Mosby.
8. Academy of Breastfeeding Medicine Protocol Committee (ABMPC). Berens, P. (ed).
(2009) ABM clinical protocol #20: engorgement. Breastfeed Med 4(2):pp. 111-3.
Retrieved from:
http://www.guideline.gov/content.aspx?id=15183&search=Pumps%2C+Breast +
25. 9. National Library of Medicine. Toxicology Data Network (TOXNET). *2011)
Trimethoprim-sulfamethoxazole. Drug and Lactation Database (LACTMED).
Retrieved from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~vP0pfa:1.
10. Clavulin. [CPhA Drug Monograph]. Retrieved from e-Therapeutics+: e-CPS:
https://www.e-therapeutics.ca/cps.showMonograph.action
11. Sulfamethoxazole-Trimethoprim [CPhA Drug Monograph]. Retrieved from e-
Therapeutics+: e-CPS: https://www.e-
therapeutics.ca/cps.select.preliminaryFilter.action?simplePreliminaryFilter=sulfamet
hoxazole#
12. Cephalexin. [CPhA Drug Monograph]. Retrieved from e-Therapeutics+: e-CPS:
https://www.e-
therapeutics.ca/cps.select.preliminaryFilter.action?simplePreliminaryFilter= cephalex
in
13. Ciprofloxacin. [CPhA Drug Monograph]. Retrieved from e-Therapeutics+: e-CPS:
https://www.e-
therapeutics.ca/cps.select.preliminaryFilter.action?simplePreliminaryFilter= ciproflox
acin
14. Cloxacillin.. [CPhA Drug Monograph]. Retrieved from e-Therapeutics+: e-CPS:
https://www.e-
therapeutics.ca/cps.showMonograph.action?simpleQuery=Cloxacillin% 20
15. College of Nurses of Ontario. (2011). Practice Standards: Nurse Practitioner Revised
2011. Toronto, ON: Author.
26. 16. Newman Breastfeeding Centre. (2009). Blocked ducts and mastitis. Retrieved from:
http://www.nbci.ca/index.php?option=com_content&view=article&id=7:blocked-
ducts-a-mastitis&catid=5:information&Itemid=17
17. Mangesi L, Dowswell T. (2010). Treatments for breast engorgement during lactation
(Review) The Cochrane Library. 9